BAM
VIR icon

Belpointe Asset Management’s Vir Biotechnology VIR Stock Holding History

Belpointe Asset Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-177
Closed -$4.12K – 3291
2023
Q1 		$4.12K Buy
177
+78
+79% +$2K ﹤0.01% 3087
2022
Q4 		$2.51K Buy
+99
New +$2.43K ﹤0.01% 3182
2021
Q4 		– Sell
-25,099
Closed -$1.09M – 1258
2021
Q3 		$1.09M Buy
+25,099
New +$1.09M 0.07% 287
2021
Q1 		– Sell
-20,559
Closed -$551K – 1078
2020
Q4 		$551K Buy
+20,559
New +$668K 0.05% 377

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return